Unknown

Dataset Information

0

Flavones scaffold of Chromolaena odorata as a potential xanthine oxidase inhibitor: Induced Fit Docking and ADME studies.


ABSTRACT: Introduction: Gout is a type of painful inflammation initiated by the interactions between monosodium urate crystals and connective tissue. Xanthine oxidase (XO) catalyzes the oxidation of hypoxanthine to xanthine, then to uric acid. The primary treatments for gout include XO inhibitors. At present, allopurinol is the most used XO inhibitor for the treatment of gout. However, it can cause adverse effects commonly known as allopurinol hypersensitivity syndrome, thereby limiting its usage. Consequently, it is necessary to develop potent and less toxic inhibitors of XO. Chromolaena odorata is one of such plants under investigation for its diverse health benefits. Methods: Phytochemicals of C. odorata were screened against XO receptor, using molecular docking. The top five hit compounds of glide docking yield flavones scaffold which were subjected to induced fit docking (IFD) and absorption, distribution, metabolism, and excretion (ADME) studies. Results: The result showed that flavones scaffold of C. odorata can bind with higher affinity and lower free energy values when compared to that of the standard, allopurinol. The IFD scores of the flavones scaffold range from -1525.25 to -1527.99 kcal/mol. Conclusion: Our results have shown that flavones scaffold might have the potential to act as an effective drug candidate when compared to allopurinol in treating and/or preventing gout and some inflammatory condition.

SUBMITTER: Kikiowo B 

PROVIDER: S-EPMC7502905 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Flavones scaffold of <i>Chromolaena odorata</i> as a potential xanthine oxidase inhibitor: Induced Fit Docking and ADME studies.

Kikiowo Babatomiwa B   Ogunleye Adewale Joseph AJ   Inyang Olumide Kayode OK   Adelakun Niyi Samuel NS   Omotuyi Olaposi Idowu OI   Metibemu Damilohun Samuel DS   David Temitope Israel TI   Oludoyi Oluwatoyin Olajide OO   Ijatuyi Taiwo Tolulope TT  

BioImpacts : BI 20191102 4


<i><b>Introduction:</b></i> Gout is a type of painful inflammation initiated by the interactions between monosodium urate crystals and connective tissue. Xanthine oxidase (XO) catalyzes the oxidation of hypoxanthine to xanthine, then to uric acid. The primary treatments for gout include XO inhibitors. At present, allopurinol is the most used XO inhibitor for the treatment of gout. However, it can cause adverse effects commonly known as allopurinol hypersensitivity syndrome, thereby limiting its  ...[more]

Similar Datasets

| PRJNA181144 | ENA
| PRJNA175228 | ENA
| PRJNA174992 | ENA
| S-EPMC7029091 | biostudies-literature
| S-EPMC7578532 | biostudies-literature
| S-EPMC6604423 | biostudies-literature
| S-EPMC3971763 | biostudies-literature
| S-EPMC11302206 | biostudies-literature
| S-EPMC10026325 | biostudies-literature
| S-EPMC6009875 | biostudies-literature